Caroline Diaz
General Counsel at DOVA PHARMACEUTICALS, INC.
Profile
Caroline Diaz is currently the Director of Regulatory Affairs at Dova Pharmaceuticals, Inc. and the Senior Vice President of Regulatory Affairs at Verona Pharma Plc.
Previously, she held the position of Vice President of Regulatory Affairs at ReViral Ltd.
Ms. Diaz completed her undergraduate degree at Hope College and her graduate degrees at The University of North Carolina at Charlotte and the University of North Carolina at Chapel Hill.
Caroline Diaz active positions
| Companies | Position | Start |
|---|---|---|
| DOVA PHARMACEUTICALS, INC. | General Counsel | - |
| VERONA PHARMA PLC | General Counsel | 01/10/2021 |
Former positions of Caroline Diaz
| Companies | Position | End |
|---|---|---|
ReViral Ltd.
 ReViral Ltd. BiotechnologyHealth Technology ReViral Ltd. specializes in the areas of virology and antiviral therapies. It offers drugs to treat respiratory synctial virus infection. The company was founded by Neil Matthews and Stuart Cockerill in 2011 and is headquartered in Stevenage, the United Kingdom. | General Counsel | - |
Training of Caroline Diaz
| Hope College | Undergraduate Degree |
| University of North Carolina at Chapel Hill | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| VERONA PHARMA PLC | Health Technology |
| Private companies | 2 |
|---|---|
Dova Pharmaceuticals, Inc.
 Dova Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Dova Pharmaceuticals, Inc. operates as a clinical-stage pharmaceutical company, which engages in the acquisition, development and commercialization of drug candidates for rare diseases. It focuses on addressing thrombocytopenia, a disorder characterized by a low blood platelet count. Its drug candidate includes avatrombopag, an orally administered thrombopoietin receptor agonist. The company was founded on March 24, 2016 and is headquartered in Durham, NC. | Health Technology |
ReViral Ltd.
ReViral Ltd. BiotechnologyHealth Technology ReViral Ltd. specializes in the areas of virology and antiviral therapies. It offers drugs to treat respiratory synctial virus infection. The company was founded by Neil Matthews and Stuart Cockerill in 2011 and is headquartered in Stevenage, the United Kingdom. | Health Technology |
- Stock Market
- Insiders
- Caroline Diaz